BioCardia, Inc.

Ticker BCDA

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in San Carlos, California

BioCardia, Inc., headquartered in San Carlos, California, is developing autologous and allogenic cell-based therapies to treat cardiovascular disease. CardiAMP™ and CardiALLO™ cell therapies are the Company’s biotherapeutic product candidates in clinical development. The Company has also developed a portfolio of approved enabling products that optimize delivery of its cell therapies.

Visit website

REPORT RATINGS

4.8 / 5.0 (136)

BioCardia, Inc. reports have an aggregate usefulness score of 4.8 based on 136 reviews.

BioCardia, Inc.